PXB-cells® - Human Primary Hepatocytes for screening anti-lipidemic drugs We are happy to share our Study Team's recent work on the use of PXB-cells for in vitro anti-lipidemic drug…
KMT Hepatech (part of PhoenixBio Group) is seeking Production Technologist for the PXB-cells Production and Transplantation Unit. The PXB-cells Production and Transplantation Unit produces cultured PXB-cells (freshly isolated human…
https://www.youtube.com/watch?v=0mVbpdu01x4PhoenixBio Group business allows use of human hepatocytes in a variety of applications and assists research of liver diseases and drug development around the world.We have production facilities in…
PXB-mouse® is one of the top most cited publications in 2015! We are happy to share the news that the development of our currently used cDNA-uPA/SCID mouse model with…
KMT Hepatech (part of PhoenixBio Group) is seeking Production Technologist for the PXB-cells Production and Transplantation Unit. The PXB-cells Production and Transplantation Unit produces cultured PXB-cells (freshly isolated human…
PXB-cells® and PXB-mouse® against viral Hepatitis PhoenixBio is attending HEP DART 2019 in beautiful Kauai, Hawaii on December 8-12, 2019.HEP DART 2019 uniquely blends the areas of biology, chemistry, pharmacology…
PXBcells® were used to generate scientific results for 10 presentations at HBV Meeting in Melbourne (Australia) and 4 presentations at AASLD Liver Meeting in Boston. Selected publications using PXB-cells in various application areas are listed below:
AASLD The Liver Meeting 2019 Boston, USA | November 8-12 Visit Booth #511 and Check Out Oral and Poster Presentations PhoenixBio would be pleased to welcome you at the…
Small Supermodel Helps Fighting Hepatitis B 2019 International HBV Meeting “The molecular biology of the hepatitis B virus” took place earlier this year in Melbourne, Australia. The aim of…
We are relocating our main office and a lab at the end of January 2019. Please, note the change in our address and phone numbers (see Contact Us page).…
